亚宝药业集团股份有限公司2025年三季度权益分派实施公告

Core Viewpoint - The announcement details the cash dividend distribution plan for Yabao Pharmaceutical Group Co., Ltd. for the third quarter of 2025, which was approved at the first extraordinary shareholders' meeting of 2026 on January 16, 2026 [2][4]. Dividend Distribution Details - The cash dividend per share is set at 0.2 RMB, amounting to a total cash dividend distribution of 138,400,009.20 RMB based on the total share capital of 692,000,046 shares [4]. - The distribution will be made to all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the equity registration [3]. Implementation Method - The dividends for unrestricted circulating shares will be distributed through the funds clearing system of China Securities Depository and Clearing Corporation Limited, with shareholders able to collect their cash dividends at their designated securities firms on the payment date [5]. - The cash dividends for the shareholder Shanshi Yabao Investment Group Co., Ltd. will be distributed directly by the company [6]. Taxation Information - For individual shareholders and securities investment funds, no income tax will be withheld at the time of cash dividend distribution. The tax will be calculated based on the holding period when the shares are sold, with specific tax rates applied depending on the duration of the holding [9]. - For Qualified Foreign Institutional Investors (QFII), a 10% withholding tax will be applied, resulting in a net cash dividend of 0.18 RMB per share after tax [10]. - For Hong Kong Stock Exchange investors, a similar 10% withholding tax applies, also resulting in a net cash dividend of 0.18 RMB per share [10]. - Resident corporate shareholders are responsible for their own tax payments, receiving the full cash dividend of 0.2 RMB per share [10]. Contact Information - For inquiries regarding this dividend distribution, shareholders can contact the company's Securities Legal Affairs Department at 010-57809936 [11].